Patent Assignment
Reel/Frame 031896/0752
Security Agreement
Recorded: 2014-01-02
Pages: 13
Assignor
SALIX PHARMACEUTICALS, LTD.
Executed: 2014-01-02
Assignee
JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
520 MADISON AVENUE, NEW YORK, NEW YORK, 10022
Covered Properties
(76)
Rifaximin Anti-Rectal Dysfunction Preparation
PCT:
PCT/US2007/005846 ↗
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
PCT:
PCT/US2007/007438 ↗
Compositions and Methods for the Treatment of Radiation Proctosigmoitis
PCT:
PCT/US2007/017379 ↗
Novel Therapeutic Targets in Bowel Disease
PCT:
PCT/US2008/080115 ↗
Forms of Rifaximin and Uses Thereof
PCT:
PCT/US2009/035192 ↗
Methods for Treating Bowel Diseases
PCT:
PCT/US2009/035348 ↗
Methods of Treating Hepatic Encephalopathy
PCT:
PCT/US2009/059321 ↗
Compositions for Bowel Preparation and Methods of Use Thereof
PCT:
PCT/US2010/028962 ↗
Methods for Treating Hepatic Encephalopathy
PCT:
PCT/US2010/037131 ↗
Modulation of Systemic Exposure to Rifaximin
PCT:
PCT/US2010/038742 ↗
Methods for Treating Irritable Bowel Syndrome (Ibs)
PCT:
PCT/US2010/048624 ↗
Methods for Treating Infection
PCT:
PCT/US2011/025170 ↗
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
PCT:
PCT/US2011/033905 ↗
New Forms of Rifaximin and Uses Thereof
PCT:
PCT/US2011/039085 ↗
Formulations of Rifaximin and Uses Thereof
PCT:
PCT/US2011/043767 ↗
Formulations of Rifaximin and Uses Thereof
PCT:
PCT/US2011/043769 ↗
Methods and Compositions for Treating Hiv-Associated Diarrhea
PCT:
PCT/US2011/058549 ↗
Forms of Rifaximin and Uses Thereof
PCT:
PCT/US2012/024746 ↗
Methods for Treating Irritable Bowel Syndrome (Ibs) and Infections
PCT:
PCT/US2012/063380 ↗
Methods for Treatment and Prevention of Opioid Induced Constipation Using Oral Compositions of Methylnaltrexone
PCT:
PCT/US2012/070612 ↗
Rifaximin Derivative and Uses Thereof
PCT:
PCT/US2013/023110 ↗
Method of Stably Treating Incontinence Using a Bulking Agent
PCT:
PCT/US2013/029542 ↗
Compositions and Methods for Treatment of Irritable Bowel Syndrome with 5-Aminosalicylate
PCT:
PCT/US2013/031848 ↗
Methods and Compositions for Treating Hiv-Associated Diarrhea
PCT:
PCT/US2013/032395 ↗
Methods of Administering Rifaximin Without Producing Antibiotic Resistance
PCT:
PCT/US2013/059415 ↗
Methods of Administering Rifaximin for Weight Loss and Treatment of Obesity
PCT:
PCT/US2013/059589 ↗
Methods of Improving Long-Term Survival and Reducing Hospitalization Readmission Rates for Subjects Suffering from Hepatic Encephalopathy
PCT:
PCT/US2013/059590 ↗
Rapidly dissolving metoclopramide solid oral dosage and method thereof
Application:
11/052,570 →
Publication:
US 2005/0137265
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Polyethylene glycol colonic purgative composition
Application:
11/982,603 →
Publication:
US 2008/0260682
Rifaximin Anti-Rectal Dysfunction Preparation
Compositions and Methods for the Treatment of Radiation Proctosigmoitis
Application:
12/309,893 →
Publication:
US 2010/0069421
Forms of Rifaximin and Uses Thereof
Methods for Treating Diarrhea-Associated Irritable Bowel Syndrome
Methods of Treating Hepatic Encephalopathy
Application:
12/572,344 →
Publication:
US 2010/0204173
Forms of Rifaximin and Uses Thereof
Methods of Treating Travelers Diarrhea and Hepatic Encephalopathy
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Forms of Rifaximin and Uses Thereof
Compositions for Bowel Preparation and Methods of Use Thereof
Application:
13/246,287 →
Publication:
US 2012/0021064
Methods and Compositions for Treating Hiv-Associated Diarrhea
Methods and Compositions for Treating Hiv-Associated Diarrhea
Application:
13/294,307 →
Publication:
US 2012/0107370
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives
Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Methods for Treating Infection
Application:
13/587,539 →
Publication:
US 2013/0210852
Forms of Rifaximin and Uses Thereof
Methods of Treating Bowel Diseases by Administering a Bowel Cleanser and an Antibiotic
Application:
13/603,647 →
Publication:
US 2013/0164384
Forms of Rifaximin and Uses Thereof
Methods for Treating Bowel Diseases
Application:
13/650,188 →
Publication:
US 2013/0137713
Methods of Treating Traveler's Diarrhea and Hepatic Encephalopathy
Methods for Treating Irritable Bowel Syndrome (Ibs) and Infections
Application:
13/667,585 →
Publication:
US 2013/0184302
Methods for Treatment and Prevention of Opioid Induced Constipation Using Oral Compositions of Methylnaltrexone
Application:
13/720,235 →
Publication:
US 2013/0317050
Methods of Treating Hepatic Encephalopathy
Methods of Treating Hepatic Encephalopathy
Method of Stably Treating Incontinence Using a Bulking Agent
Application:
13/788,401 →
Publication:
US 2014/0005142
Compositions and Methods for Treatment of Irritable Bowel Syndrome with 5-Aminosalicylate
Application:
13/832,440 →
Publication:
US 2013/0316000
Methods and Compositions for Treating Hiv-Associated Diarrhea
Application:
13/840,861 →
Publication:
US 2014/0163096
Methods of Treating Hepatic Encephalopathy
Forms of Rifaximin and Uses Thereof
Formulations and Uses of 2-Hydroxy-5-Phenylazobenzoic Acid Derivatives for the Treatment of Males
Application:
13/938,777 →
Publication:
US 2013/0295178
Forms of Rifaximin and Uses Thereof
Application:
13/949,684 →
Publication:
US 2013/0310409
New Forms of Rifaximin and Uses Thereof
Forms of Rifaximin and Uses Thereof
Application:
14/031,731 →
Method of Stably Treating Incontinence Using a Bulking Agent
Application:
14/058,836 →
Publication:
US 2014/0045788
Forms of Rifaximin and Uses Thereof
Automatic Injection Device
Patent:
715,422 →
Application:
29/422,358 →
Methods and Compositions for Treating Ibs
Application:
61/559,686 →
Methods and Compositions for Treating Irritable Bowel Syndrome (Ibs)
Application:
61/560,133 →
Methods and Compositions for Treating Irritable Bowel Syndrome (Ibs)
Application:
61/560,267 →
Methods and Compositions for Treating Ibs
Application:
61/560,788 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 8, 2013
From: WU, YIDUO; PARENT, STEPHAN D.; SCHULTHEISS, NATHAN CARL; BEVILL, MELANIE JANELLE
To: APTUIT, INC.
Reel/Frame 030750/0317 →
Assignment of Assignor's Interest
Nov 5, 2013
From: GOLDEN, PAM; KABIR, MOHAMMED A.
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 031542/0423 →
Assignment of Assignor's Interest
Nov 5, 2013
From: VISCOMI, GIUSEPPE CLAUDIO; CAMPANA, MANUELA; CONFORTINI, DONATELLA; BARBANTI, MIRIAM
To: ALFA WASSERMANN S.P.A.
Reel/Frame 031542/0474 →
Assignment of Assignor's Interest
Dec 26, 2013
From: CHANG, CHRISTOPHER; PIMENTEL, MARK
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 031847/0529 →
Assignment of Assignor's Interest
Jan 27, 2014
From: BORTEY, ENOCH
To: SALIX PHARMACEUTICALS, LTD
Reel/Frame 032053/0477 →
Assignment of Assignor's Interest
Feb 6, 2014
From: WILMINGTON PHARMACEUTICALS, LLC
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 032155/0880 →
Assignment of Assignor's Interest
Feb 6, 2014
From: HALEY, EUGENE T.
To: WILMINGTON PHARMACEUTICALS, LLC
Reel/Frame 032155/0822 →
Assignment of Assignor's Interest
Jun 11, 2014
From: FRANKLIN, HOWARD
To: SALIX PHARMACEUTICALS, LTD
Reel/Frame 033080/0865 →
Corrective Assignment to Correct the Pct Number US1207061 Previously Recorded on Reel 032053 Frame 0477. Assignor(S) Hereby Confirms the Pct Number: Pct/US2012/070612.
Jul 31, 2014
From: BORTEY, ENOCH
To: SALIX PHARMACEUTICALS, LTD
Reel/Frame 033452/0772 →
Assignment of Assignor's Interest
Oct 28, 2014
From: SALIX PHARMACEUTICALS, LTD.
To: DR. FALK PHARMA GMBH
Reel/Frame 034052/0334 →
Assignment of Assignor's Interest
Dec 11, 2014
From: GUSHURST, KAREN S.; YANG, DONGLAI; VLAHOVA, PETINKA; STULTS, JEFFREY S.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 034477/0647 →
Assignment of Assignor's Interest
Mar 26, 2015
From: FORBES, WILLIAM; BORTEY, ENOCH; GOLDEN, PAM
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 035264/0014 →
Release of Security Interest
Apr 1, 2015
From: JEFFERIES FINANCE LLC
To: SALIX PHARMACEUTICALS, LTD.
Reel/Frame 035353/0661 →
Security Agreement
Apr 2, 2015
From: GLYCYX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD.; SANTARUS, INC.
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 035364/0396 →
Assignment of Assignor's Interest
Aug 20, 2015
From: NEFF, GUY
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 036406/0956 →
Intellectual Property Security Agreement
Feb 12, 2016
From: JAGUAR ANIMAL HEALTH, INC.
To: HERCULES TECHNOLGY GROWTH CAPITAL, INC., AS AGENT
Reel/Frame 037809/0161 →
Assignment of Assignor's Interest
Mar 7, 2016
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 037910/0987 →
Assignment of Assignor's Interest
Apr 1, 2016
From: SALIX PHARMACEUTICALS, INC.
To: NAPO PHARMACEUTICALS, INC.
Reel/Frame 038168/0355 →
Security Interest
Jul 19, 2017
From: SALIX PHARMACEUTICALS, LTD
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043041/0880 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Assignment of Assignor's Interest
May 6, 2019
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 049090/0053 →
Assignment of Assignor's Interest
May 13, 2019
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 049157/0940 →
Assignment of Assignor's Interest
Jun 12, 2019
From: SALIX PHARMACEUTICALS, LTD.
To: SALIX PHARMACEUTICALS, INC.
Reel/Frame 049444/0911 →